4,4'-dinitrostilbene-2,2'-disulfonic acid | 78333-25-2

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 4,4'-dinitrostilbene-2,2'-disulfonic acid
• 英文别名: 4,4'-dinitro-stilbene-2,2'-disulphonic acid；NSC 1793；5-nitro-2-[(E)-2-(4-nitro-2-sulfophenyl)ethenyl]benzenesulfonic acid
• CAS: 78333-25-2
• 化学式: C₁₄H₁₀N₂O₁₀S₂
• 分子量: 430.373
• InChiKey: UETHPMGVZHBAFB-OWOJBTEDSA-N

物化性质

• 密度：
  1.779±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  28
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  217
• 氢给体数：
  2
• 氢受体数：
  10

ADMET

毒理性

• 副作用

职业性肝毒素 - 第二性肝毒素：在职业环境中的毒性效应潜力是基于人类摄入或动物实验的中毒案例。

Occupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.

来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

反应信息

• 作为反应物：
  描述：

  4,4'-dinitrostilbene-2,2'-disulfonic acid 以97%的产率得到
  参考文献：
  名称：

  PARYJCZAK, TADEUSZ;BALCZEWSKA, HANNA

  摘要：

  DOI：
• 作为产物：
  描述：

  4,4'-二硝基二苯乙烯-2,2'-二磺酸钠 生成 4,4'-dinitrostilbene-2,2'-disulfonic acid
  参考文献：
  名称：

  摘要：

  DOI：

文献信息

• Aryl sulfonic acids and derivatives as FSH antagonists
  申请人：American Home Products Corporation

  公开号：US06355633B1

  公开（公告）日：2002-03-12

  This invention provides compounds of formula I having the structure wherein R1, Ar, Ar′, and Q are as defined in the specification, or a pharmaceutically acceptable salt thereof, which are useful as contraceptive agents.

  这项发明提供了具有结构的化合物I的公式，其中R1、Ar、Ar'和Q如规范中定义，或其药用可接受盐，这些化合物可用作避孕剂。
• Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
  申请人：Zhang Jun Jin

  公开号：US20050159410A1

  公开（公告）日：2005-07-21

  A treatment solution used to prevent posterior capsular opacification is applied or introduced into the lens capsular bag before, during, or after cataract surgery. The treatment solution may also be applied to an intraocular lens prior to surgery. The treatment solution comprises an ion transport mechanism interference agent, which either alone or in combination with other treatment agents such as an osmotic stress agent and an agent to establish a suitable pH, selectively induces detachment and/or death of lens epithelial cells such that posterior capsular opacification is prevented. While the ion transport mechanism interference agent is capable of interfering with the cellular mechanisms and cell ion distribution of a broad range of cells, a concentration of agent is selected such that the treatment solution interferes selectively with the cellular mechanisms of lens epithelial cells while leaving other ocular cells substantially unharmed. The treatment solution selectively induces cellular death and/or detachment of lens epithelial cells while other ocular cells and tissue remain substantially unharmed and without lengthy preoperative pre-treatment.

  一种用于预防后囊膜混浊的治疗方案被应用或引入到白内障手术之前、期间或之后的晶状体囊袋中。治疗方案也可以在手术前应用于人工晶体。该治疗方案包括离子传输机制干扰剂，该干扰剂单独或与其他治疗剂（如渗透应激剂和用于建立适当pH的剂）结合使用，有选择地诱导晶状体上皮细胞的脱离和/或死亡，从而预防后囊膜混浊。虽然离子传输机制干扰剂能够干扰广泛范围细胞的细胞机制和细胞离子分布，但选择了一定浓度的干扰剂，使治疗方案有选择性地干扰晶状体上皮细胞的细胞机制，同时基本不伤害其他眼部细胞。该治疗方案有选择性地诱导晶状体上皮细胞的细胞死亡和/或脱离，而其他眼部细胞和组织基本不受伤害，并且无需冗长的术前预处理。
• MATERIAL FOR PHOTOELECTRIC CONVERSION ELEMENT FOR USE IN IMAGING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT INCLUDING SAME
  申请人：NIPPON KAYAKU KABUSHIKI KAISHA

  公开号：US20170040550A1

  公开（公告）日：2017-02-09

  The present invention provides a material for photoelectric conversion elements for use in imaging elements which comprises a compound represented by the following formula (1). The material for photoelectric conversion elements for use in imaging elements, which comprises a compound represented by the following formula (1), is used to produce a photoelectric conversion element which is excellent in terms of hole- or electron-leakage prevention, thermal resistance to processing temperatures, transparency to visible light, etc. (In formula (1), R 1 and R 2 each independently represent a substituted or unsubstituted aromatic group.)

  本发明提供了一种用于成像元件中的光电转换元件的材料，该材料包括以下式（1）所代表的化合物。用于成像元件中的光电转换元件的材料包括以下式（1）所代表的化合物，用于制备具有优异的阻止孔隙或电子泄漏、耐热性、对可见光透明等特性的光电转换元件。（在式（1）中，R1和R2各自独立地表示取代或未取代的芳香基。）
• Method for producing monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds
  申请人：——

  公开号：US20040073041A1

  公开（公告）日：2004-04-15

  The invention relates to a method for producing monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds by ozonizing, unsaturated organic carbon compounds that, per molecule, have one or more olefinic or aromatic double bonds, which can be cleaved by ozone, and by subsequently processing the ozonization products. According to the inventive method, unsaturated organic carbon compounds that, per molecule, have one or more olefinic or aromatic double bonds, which can be cleaved by ozone, are: (a) in 1 to 2 steps, continuously reacted with ozone in stoichiometric quantities or in excess while using counter educt currents and being in an organic solvent or in an aqueous solution inside a device, which consists of one to two absorption apparatuses, of devices for carrying away reaction heat, and of devices for separating the gas and liquid phases, and; (b) the peroxides resulting therefrom are, according to reaction parameters from step (a), converted into the corresponding monocarbonyl compounds or biscarbonyl compounds or hydroxyl compounds either by continuous or discontinuous hydrogenation, oxidation or heating.

  本发明涉及一种通过臭氧化具有一个或多个烯丙基或芳香双键的分子，可被臭氧裂解的不饱和有机碳化合物来生产单羰基化合物、双羰基化合物或羟基化合物的方法，并随后处理臭氧化产物。根据本发明的方法，具有一个或多个烯丙基或芳香双键，可被臭氧裂解的不饱和有机碳化合物：(a)在1至2步中，在有机溶剂或水溶液中，使用对流反应并使用反应热带有吸收装置、用于带走反应热的装置和用于分离气体和液体相的装置，在化学计量量或过量的情况下连续与臭氧反应；(b)根据步骤(a)的反应参数，将所得的过氧化物通过连续或间歇的氢化、氧化或加热转化为相应的单羰基化合物、双羰基化合物或羟基化合物。
• Phosphate transport inhibitors
  申请人：Jozefiak H. Thomas

  公开号：US20070021509A1

  公开（公告）日：2007-01-25

  Disclosed are compounds which have been identified as inhibitors of phosphate transport. Many of the compounds are represented by Structural Formula (I): Ar 1 —W—X—Y—Ar 2 ; or a pharmaceutically acceptable salt thereof. Ar 1 and Ar 2 are independently a substituted or unsubstituted aryl group or an optionally substituted five membered or six membered non-aromatic heterocylic group fused to an optionally substituted monocylic aryl group. W and Y are independently a covalent bond or a C1-C3 substituted or unsubstituted alkylene group. X is a heteroatom-containing functional group, an aromatic heterocyclic group, substituted aromatic heterocyclic group, non-aromatic heterocyclic group, substituted non-aromatic heterocyclic group, an olefin group or a substituted olefin group. Also disclosed are methods of treating a subject with a disease associated with hyperphosphatemia, as well as a disease mediated by phosphate-transport function. The methods comprise the step of administering an effective amount of the one of the compounds described above.

  本发明涉及已被鉴定为磷酸盐转运抑制剂的化合物。其中许多化合物由结构式（I）表示：Ar1-W-X-Y-Ar2；或其药学上可接受的盐。其中，Ar1和Ar2独立地为取代或未取代的芳基团或可选取代的五元或六元非芳基杂环团与可选取代的单环芳基团融合。W和Y独立地为共价键或C1-C3取代或未取代的烷基链。X为含杂原子的官能团、芳基杂环团、取代的芳基杂环团、非芳基杂环团、取代的非芳基杂环团、烯烃基或取代的烯烃基。本发明还涉及治疗与高磷血症相关的疾病以及由磷酸盐转运功能介导的疾病的方法。该方法包括给予上述化合物之一的有效量。